Author/Authors
Koçyiğit, İsmail Doruk Kırıkkale Üniversitesi - Diş Hekimliği Fakültesi - Ağız, Diş ve Çene Cerrahisi Anabilim Dalı, Türkiye , Tunalı, Mustafa GATA Haydarpaşa Eğitim Hastanesi - Diş Hekimliği, Periodontoloji Anabilim Dalı, Türkiye , Özdemir, Hakan Cumhuriyet Üniversitesi - Diş Hekimliği Fakültesi - Periodontoloji Anabilim Dalı, Türkiye , Kartal, Yasemin , Süer, Berkay Tolga GATA Haydarpaşa Eğitim Hastanesi - Diş Hekimliği, Ağız, Diş ve Çene Cerrahisi Anabilim Dalı, Türkiye
Title Of Article
Clinical application of second generation trombosite concentration
شماره ركورد
37641
Abstract
The therapeutic use of autologous platelet-rich fibrin constitutes a relatively new biotechnology that has been a breakthrough in the stimulation and acceleration of soft-tissue and bone healing. The efficiency of this process lies in the local and continuous delivery of a wide range of growth factors and proteins, mimicking the needs of the physiological wound healing and reparative tissue processes. Platelet-rich fibrin (PRF) belongs to a new generation of platelet concentrates, with simplified processing and without biochemical blood handling. This easy protocol allows the production of leukocyte and platelet-rich fibrin clots starting from autologous blood samples. PRF is used especially in clinical Periodontal and Oral and Maxillofacial Surgery applications. The significance of the PRF is gradually increasing
From Page
279
NaturalLanguageKeyword
Platelet , autogenous fibrine , growth hormone
JournalTitle
Cumhuriyet Dental Journal
To Page
287
JournalTitle
Cumhuriyet Dental Journal
Link To Document